title: An investigation of the antidepressant action of xiaoyaosan in rats using ultra performance liquid chromatography-mass spectrometry combined with metabonomics.
abstract: A rapid, highly sensitive, and selective method was applied in a non-invasive way to investigate the antidepressant action of Xiaoyaosan (XYS) using ultra performance liquid chromatography-mass spectrometry (UPLC-MS) and chemometrics. Many significantly altered metabolites were used to explain the mechanism. Venlafaxine HCl and fluoxetine HCl were used as chemical positive control drugs with a relatively clear mechanism of action to evaluate the efficiency and to predict the mechanism of action of XYS. Urine obtained from rats subjected to chronic unpredictable mild stress (CUMS) was analyzed by UPLC-MS. Distinct changes in the pattern of metabolites in the rat urine after CUMS production and drug intervention were observed using partial least squares-discriminant analysis. The results of behavioral tests and multivariate analysis showed that CUMS was successfully reproduced, and a moderate-dose XYS produced significant therapeutic effects in the rodent model, equivalent to those of the positive control drugs, venlafaxine HCl and fluoxetine HCl. Metabolites with significant changes induced by CUMS were identified, and 17 biomarker candidates for stress and drug intervention were identified. The therapeutic effect of XYS on depression may involve regulation of the dysfunctions of energy metabolism, amino acid metabolism, and gut microflora changes. Metabonomic methods are valuable tools for measuring efficacy and mechanisms of action in the study of traditional Chinese medicines.
authors.affiliation: Modern Research Center for Traditional Chinese Medicine of Shanxi University, No.92, Wucheng Road, Taiyuan 030006, PR China.
authors.forename: Xiao-Xia
authors.initials: XX
authors.lastname: Gao
authors.forename: Jie
authors.initials: J
authors.lastname: Cui
authors.forename: Xing-Yu
authors.initials: XY
authors.lastname: Zheng
authors.forename: Zhen-Yu
authors.initials: ZY
authors.lastname: Li
authors.forename: Young-Hae
authors.initials: YH
authors.lastname: Choi
authors.forename: Yu-Zhi
authors.initials: YZ
authors.lastname: Zhou
authors.forename: Jun-Sheng
authors.initials: JS
authors.lastname: Tian
authors.forename: Jie
authors.initials: J
authors.lastname: Xing
authors.forename: Xiao-Jie
authors.initials: XJ
authors.lastname: Tan
authors.forename: Guan-Hua
authors.initials: GH
authors.lastname: Du
authors.forename: Xue-Mei
authors.initials: XM
authors.lastname: Qin
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use* / Q000652:urine; D001565:Benzoates / Q000652:urine; D015415:Biomarkers / Q000652:urine; D001952:Bridged-Ring Compounds / Q000652:urine; D002392:Catechin / Q000652:urine; D002599:Chalcone / Q000031:analogs & derivatives / Q000652:urine; D002853:Chromatography, Liquid; D019343:Citric Acid / Q000652:urine; D002952:Citric Acid Cycle / Q000187:drug effects; D003373:Coumaric Acids / Q000652:urine; D003402:Creatine Kinase / Q000187:drug effects / Q000652:urine; D003404:Creatinine / Q000652:urine; D003511:Cyclohexanols / Q000627:therapeutic use; D004365:Drugs, Chinese Herbal / Q000032:analysis / Q000627:therapeutic use*; D044950:Flavanones / Q000652:urine; D005473:Fluoxetine / Q000627:therapeutic use; D005707:Gallic Acid / Q000652:urine; D041981:Gastrointestinal Tract / Q000382:microbiology*; D005960:Glucosides / Q000652:urine; D005998:Glycine / Q000031:analogs & derivatives / Q000187:drug effects / Q000652:urine; D006626:Hippurates / Q000652:urine; D007656:Ketoglutaric Acids / Q000652:urine; D007736:Kynurenic Acid / Q000652:urine; D008297:Male; D013058:Mass Spectrometry; D053858:Metabolic Networks and Pathways / Q000187:drug effects*; D055432:Metabolomics; D064307:Microbiota / Q000187:drug effects*; D039821:Monoterpenes; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D013315:Stress, Psychological / Q000188:drug therapy; D014364:Tryptophan / Q000187:drug effects / Q000652:urine; D014443:Tyrosine / Q000187:drug effects / Q000652:urine; D000069470:Venlafaxine Hydrochloride; D006027:Glycosides
chemical_list: D000928:Antidepressive Agents; D001565:Benzoates; D015415:Biomarkers; D001952:Bridged-Ring Compounds; D002392:Catechin; D002599:Chalcone; D019343:Citric Acid; D003373:Coumaric Acids; D003402:Creatine Kinase; D003404:Creatinine; D003511:Cyclohexanols; D004365:Drugs, Chinese Herbal; D044950:Flavanones; D005473:Fluoxetine; D005707:Gallic Acid; D005960:Glucosides; D005998:Glycine; D006626:Hippurates; D007656:Ketoglutaric Acids; D007736:Kynurenic Acid; D039821:Monoterpenes; D010936:Plant Extracts; D014364:Tryptophan; D014443:Tyrosine; D000069470:Venlafaxine Hydrochloride; C532268:xiaoyaosan; C015423:peoniflorin; D006027:Glycosides; C098467:neoisoliquiritin; C014959:albiflorin; C022050:phenylacetylglycine; C004999:ferulic acid; C512196:liquiritin; C030514:hippuric acid